Coronary Artery Disease Clinical Trial
Official title:
Functional Assessment of Myocardial Ischemia by Intracoronary Electrocardiogram
In patients with chronic stable coronary artery disease (CAD), percutaneous coronary
intervention (PCI) targets hemodynamically significant coronary lesions, i.e., those thought
to cause inducible ischemia. The hemodynamic severity of a coronary stenosis increases with
its tightness and with the myocardial mass of viable myocardium downstream of the stenosis.
Compared to the traditional anatomic angiographic approach, assessment of functional
relevance by fractional flow reserve (FFR) during coronary angiography has been suggested to
improve patient outcomes. Fractional flow reserve (FFR) is based on determination of the
coronary perfusion pressure downstream of a stenosis during pharmacologic hyperemia. However,
FFR relies on oversimplified physiologic concepts, which limits its usefulness in defining a
true ischemic threshold. Furthermore, visual angiographic assessment continues to dominate
the treatment decisions for intermediate coronary lesions.
Conversely, the intracoronary ECG (icECG) provides an inexpensive, sensitive and direct
measure of myocardial ischemia. The icECG is easily acquired by attaching a reusable
alligator clamp to a conventional angioplasty guidewire (at one tenth the price of a pressure
sensor guidewire). The coronary guide wire positioned downstream of a coronary stenosis then
acts as the exploring electrode. During pharmacologic stress, the icECG can provide direct
evidence for regional myocardial ischemia to define the ischemic threshold in different types
of coronary artery disease.
INVASIVE PRESSURE-DERIVED INDICES OF STENOSIS SEVERITY
In the setting of stable coronary artery disease (CAD), PCI or coronary artery bypass
grafting (CABG) targets coronary lesions causing inducible myocardial ischemia. With the
advancement of technology, the development of a coronary pressure guide wire enabled to
reliably measure coronary perfusion pressure downstream of a stenosis and therefore
trans-stenotic pressure gradients. On the basis of comparisons to noninvasive stress tests,
the concept of fractional flow reserve (FFR) was introduced. FFR determines the ratio of mean
distal coronary pressure and mean aortic pressure (the effective coronary perfusion pressure)
during (pharmacologic) hyperemia. A FFR value of near 1 is then equivalent to a totally
normal coronary artery, whereas a cutoff of 0.75-0.80 is commonly used to determine that PCI
is warranted.
With FFR, pharmacologic hyperemia is mandatory to induce minimal and constant myocardial
resistance, which is the basis to directly relate coronary pressure and flow.In contrast, the
recently introduced concept of the instantaneous wave-free ratio (iFR) claims to obviate the
need for administration of pharmacologic stress. Instead, coronary pressure is analyzed at
rest and during part of coronary diastole, when myocardial resistance is thought to be
naturally constant and minimal (the so called wave-free period).
LIMITATIONS OF PRESSURE-DERIVED INDICES OF STENOSIS SEVERITY IN DEFINING THE ISCHEMIC
THRESHOLD
A major limitation of pressure-derived indices of stenosis severity is related to the
assumption of oversimplified physiologic concepts. Clinically, the diagnostic accuracy of FFR
is restricted in three scenarios. Firstly, the pressure gradient evaluated by FFR is
critically dependent on the magnitude of resistance offered by the microcirculation. With
microvascular dysfunction, microvascular resistance remains inadequately high during
pharmacologic hyperemia, meaning that the pressure gradient across the stenosis does not
reflect the epicardial stenosis severity (overestimation of FFR).
Secondly, with a focal stenosis, but well-preserved microvascular function and minimal
diffuse atherosclerosis, hyperemic coronary flow (although reduced) may still be above the
ischemic threshold, although the pressure gradient suggests otherwise. Thirdly, with severe
diffuse coronary atherosclerosis, coronary flow may be reduced below the ischemic threshold,
but with only an insignificant fall in the hyperemic pressure gradient (FFR). In summary,
although FFR claims otherwise, the ischemic threshold set by FFR is unreliable in a
significant proportion of pathophysiological and clinical scenarios.
DIRECT ASSESSMENT OF REVERSIBLE MYOCARDIAL ISCHEMIA BY INTRACORONARY ELECTROCARDIOGRAM
The electrocardiogram (ECG) is an indispensable tool in the diagnosis of myocardial ischemia.
The commonly used surface ECG is however limited especially in detecting short-lasting, or
minor myocardial ischemia. Furthermore, ischemia in the territory of the left circumflex
coronary artery is often undetected. Conversely, due to its close vicinity to the myocardium,
the intracoronary ECG (icECG) is much more sensitive in detecting acute myocardial ischemia.
The icECG is obtained by attaching a reusable alligator clamp to a coronary guidewire. With
the guidewire positioned in a coronary artery, the derived (pseudo)unipolar icECG reflects
local epicardial ECG.
The value of the icECG was first shown by Friedman et al. Unipolar icECG was recorded during
balloon dilatation of coronary stenosis from the guidewire positioned across the stenosis to
be dilated. Ischemic changes in icECG was observed in 72% of stenoses dilated. In the cases
with no ischemic changes, either a prior myocardial infarction in the territory undergoing
balloon dilatation or angiographic collaterals were present, consistent with the notion that
ischemia was not inducible in nonviable myocardium or prevented by sufficient collaterals. Of
note, ST changes in the surface ECG were seen in only 31% of cases.
With acute and complete coronary occlusion, perfusion to the dependent territory is usually
severely reduced which explains the frequent occurrence of icECG changes. However, the
usefulness of the icECG has also been shown with partial coronary occlusion. Experimentally,
Battler et al. demonstrated that during a partial stenosis producing only mild regional
dysfunction, significant ST segment changes in regional epicardial ECG could be observed
after 2-3 minutes. Clinically, Hishikari et al. showed in patients with non-ST-segment
elevation myocardial infarction (NSTEMI) that ST-segment-elevation in the icECG (icECG-STE)
was observed in 27.6% of patients before PCI and was more common with LCX culprit lesions.
Furthermore, in multivariate analysis, icECG-STE predicted greater peak values of troponin
levels, consistent with greater myocardial injury. Similarly, but in patients undergoing
elective PCI, Uetani et al. showed that icECG provided a useful method to predict
post-procedural myocardial injury.
With regard to detection of inducible ischemia by pharmacologic (vasodilator) stress, Balian
et al. compared STsegment shift in the icECG (IST) during intravenous adenosine infusion with
FFR in 48 patients. 81% of patients with an FFR ≤0.80 showed IST during adenosine infusion,
while 14% had IST with an FFR >0.80. As a major limitation, the study compared icECG findings
only with FFR and therefore, the mechanism of discordant results remained unclear.
Furthermore, the choice of the pharmacologic stressor was questionable: the perfusion
abnormalities induced by adenosine are the result of flow heterogeneity, in contrast to
exercise (or inotropic pharmacologic stress, eg. dobutamine), where the perfusion
abnormalities are the result of myocardial ischemia (detectable by the electrocardiogram).
Thus, the goal of this study is to test the accuracy of intracoronary (ic) ECG during
pharmacologic inotropic stress (i.e. Imitation of daily physical activity) to determine
significant coronary lesions in comparison with established physiologic indices (fractional
flow reserve (FFR), instantaneous wave-free ratio (iFR)) as well as with quantitatively
determined percent diameter stenosis (%S) using biplane coronary angiography.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |